Intensive diabetes therapy reduces the prevalence of coronary calcification and progression of atherosclerosis and the risk of cardiovascular disease (CVD) events in the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interven-tions and Complications (EDIC) study. The effects of intensive therapy on measures of cardiac function and structure and their association with glycemia have not been explored in type 1 diabetes (T1DM). We assess whether intensive treatment com-pared with conventional treatment during the DCCT led to differences in these parameters during EDIC. After 6.5 years of intensive versus conventional therapy in the DCCT, and 15 years of additional follow-up in EDIC, left ventricular (LV) indices were ...
OBJECTIVE — Randomized treatment comparing an intensive glycemic treatment strategy with a standard ...
OBJECTIVE — To determine if baseline subgroups in the Action to Control Cardiovascular Risk in Diabe...
Objectives. In a cohort of type 2 diabetic (T2D) patients who underwent baseline cardiac magnetic re...
BACKGROUND—Intensive diabetes therapy aimed at achieving near normoglycemia reduces the risk of micr...
Objective. To investigate whether the use of intensive glycemic control versus conventional therapy ...
To describe the beneficial long-term effects of an average of 6.5 years of intensive diabetes therap...
OBJECTIVE Individuals with diabetes have higher resting heart rate compared with those without, whic...
Aims: We assessed whether and to what extent established cardiovascular disease (CVD) risk factors m...
ventions and Complications (DCCT/EDIC) study continues to address knowledge gaps in our understandin...
OBJECTIVEThe influence of diabetes on cardiac resynchronization therapy (CRT) remains unclear. The a...
The Diabetes Control and Complications Trial (DCCT) was designed to test the glucose hypothesis and ...
The Diabetes Control and Complications Trial (DCCT) and its observational follow-up Epidemiology of ...
OBJECTIVE—This study investigated the hypothesis that base-line calcified coronary atherosclerosis m...
Aims: Little is known about the long-term effects of intensive multifactorial treatment early in th...
peer reviewedThe "Diabetes Control and Complications Trial" (DCCT) demonstrated that intensive insul...
OBJECTIVE — Randomized treatment comparing an intensive glycemic treatment strategy with a standard ...
OBJECTIVE — To determine if baseline subgroups in the Action to Control Cardiovascular Risk in Diabe...
Objectives. In a cohort of type 2 diabetic (T2D) patients who underwent baseline cardiac magnetic re...
BACKGROUND—Intensive diabetes therapy aimed at achieving near normoglycemia reduces the risk of micr...
Objective. To investigate whether the use of intensive glycemic control versus conventional therapy ...
To describe the beneficial long-term effects of an average of 6.5 years of intensive diabetes therap...
OBJECTIVE Individuals with diabetes have higher resting heart rate compared with those without, whic...
Aims: We assessed whether and to what extent established cardiovascular disease (CVD) risk factors m...
ventions and Complications (DCCT/EDIC) study continues to address knowledge gaps in our understandin...
OBJECTIVEThe influence of diabetes on cardiac resynchronization therapy (CRT) remains unclear. The a...
The Diabetes Control and Complications Trial (DCCT) was designed to test the glucose hypothesis and ...
The Diabetes Control and Complications Trial (DCCT) and its observational follow-up Epidemiology of ...
OBJECTIVE—This study investigated the hypothesis that base-line calcified coronary atherosclerosis m...
Aims: Little is known about the long-term effects of intensive multifactorial treatment early in th...
peer reviewedThe "Diabetes Control and Complications Trial" (DCCT) demonstrated that intensive insul...
OBJECTIVE — Randomized treatment comparing an intensive glycemic treatment strategy with a standard ...
OBJECTIVE — To determine if baseline subgroups in the Action to Control Cardiovascular Risk in Diabe...
Objectives. In a cohort of type 2 diabetic (T2D) patients who underwent baseline cardiac magnetic re...